A Study to Explore Prognoses of NSCLC Patients Complicated With Oligometastases
NCT ID: NCT03427541
Last Updated: 2018-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2017-12-31
2018-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer
NCT03413956
A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer
NCT03427567
A Study to Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC Patients
NCT03429673
A Study to Explore Clinical Characteristics and Prognoses of N2 Patients With Non-small Cell Lung Cancer
NCT03429192
A Study to Evaluate Clinical Characteristics of Lung Cancer in Patients With Surgeries and Adjuvant Therapies
NCT03421093
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with surgeries
NSCLC patients with surgeries
Surgeries
Surgeries
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surgeries
Surgeries
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Tumor metastases in one organ (no more than 3 metastases);
Exclusion Criteria
* Patients with pleural dissemination or invasion of extrapulmonary organs;
* Patients with supraclavicular lymph node metastasis;
* Patients with systematic diseases that would influence patient survivals;
* Patients with no records for visits;
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
LinkDoc Technology (Beijing) Co. Ltd.
INDUSTRY
Tang-Du Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhang Helong
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
China PLA General Hospital
Beijing, Beijing Municipality, China
Henan cancer hospital
Zhengzhou, Henan, China
Tongji Hospital Affiliated to Huazhong Technology Hospital
Wuhan, Hubei, China
Jiangsu cancer hospital
Nanjing, Jiangsu, China
Xi'an Tangdu Hospital
Xi'an, Shaanxi, China
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, China
Huaxi Hospital Affiliated to Sichuan University
Chengdu, Sichuan, China
Tianjin Chest Hospital
Tianjin, Tianjin Municipality, China
First Hospital Affiliated to Zhejiang University
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WTONG05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.